These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 37680888)
21. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868 [TBL] [Abstract][Full Text] [Related]
22. Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways. Jiang R; Lönnerdal B Int J Biochem Cell Biol; 2012 Jan; 44(1):91-100. PubMed ID: 22009034 [TBL] [Abstract][Full Text] [Related]
23. Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation. Fukuma Y; Sakai E; Nishishita K; Okamoto K; Tsukuba T Biofactors; 2015; 41(4):222-31. PubMed ID: 26154488 [TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Halevy O; Cantley LC Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438 [TBL] [Abstract][Full Text] [Related]
25. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway. Guo H; Ding D; Wang L; Yan J; Ma L; Jin Q PLoS One; 2021; 16(12):e0261127. PubMed ID: 34914744 [TBL] [Abstract][Full Text] [Related]
26. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts. Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory Effect of LGS and ODE Isolated from the Twigs of Kim GR; Kim EN; Park KJ; Kim KH; Jeong GS Molecules; 2021 Mar; 26(6):. PubMed ID: 33810014 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma. Chea C; Haing S; Miyauchi M; Shrestha M; Imanaka H; Takata T Biochem Biophys Res Commun; 2019 Jan; 508(3):946-952. PubMed ID: 30545626 [TBL] [Abstract][Full Text] [Related]
29. Akt promotes BMP2-mediated osteoblast differentiation and bone development. Mukherjee A; Rotwein P J Cell Sci; 2009 Mar; 122(Pt 5):716-26. PubMed ID: 19208758 [TBL] [Abstract][Full Text] [Related]
30. Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway. Dong M; Zeng J; Yang C; Qiu Y; Wang X Front Pharmacol; 2022; 13():829741. PubMed ID: 35211021 [TBL] [Abstract][Full Text] [Related]
31. Chitosan oligosaccharide promotes osteoclast formation by stimulating the activation of MAPK and AKT signaling pathways. Bai BL; Xie ZJ; Weng SJ; Wu ZY; Li H; Tao ZS; Boodhun V; Yan DY; Shen ZJ; Tang JH; Yang L J Biomater Sci Polym Ed; 2018 Jul; 29(10):1207-1218. PubMed ID: 29502489 [TBL] [Abstract][Full Text] [Related]
32. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism. Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112 [TBL] [Abstract][Full Text] [Related]
33. Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells. Kim EC; Park J; Noh G; Park SJ; Noh K; Kwon IK; Ahn SJ Bioelectromagnetics; 2018 Jul; 39(5):394-404. PubMed ID: 29709064 [TBL] [Abstract][Full Text] [Related]
34. QingYan formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways. Zhao Y; Xu Y; Zheng H; Lin N J Ethnopharmacol; 2021 Mar; 268():113644. PubMed ID: 33264660 [TBL] [Abstract][Full Text] [Related]
35. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. Bordukalo-Nikšić T; Kufner V; Vukičević S Front Immunol; 2022; 13():869422. PubMed ID: 35558080 [TBL] [Abstract][Full Text] [Related]
36. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation. Han SY; Lee KH; Kim YK Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250 [TBL] [Abstract][Full Text] [Related]
37. Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT. Liu J; Zhang Z; Guo Q; Dong Y; Zhao Q; Ma X Phytomedicine; 2018 Mar; 42():43-50. PubMed ID: 29655696 [TBL] [Abstract][Full Text] [Related]
38. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts. Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934 [TBL] [Abstract][Full Text] [Related]
39. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. Li XJ; Zhu Z; Han SL; Zhang ZL Int J Mol Med; 2016 Dec; 38(6):1661-1672. PubMed ID: 27840967 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways. Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]